Crossmark

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

Published Online: 2022-02-12

Published Print: 2022-12

Authors

Han, Wei

Wang, Nan

Kong, Rui

Bao, Wen

Lu, Jie http://orcid.org/0000-0001-5628-3036
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No. 81770518)
License Information

Text and Data Mining valid from 2022-02-12

Version of Record valid from 2022-02-12
More Information

Article History

Received: 16 November 2021

Accepted: 31 January 2022

First Online: 12 February 2022

Declarations

:

: This study was approved by the human study ethics committees at Shanghai Tenth People’s Hospital (ID SHSY-IEC-4.1/20-261/01). All patients provided written informed consent for participation in the study. Specimens were handled in accordance with legal and ethical regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current